BHC's fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.

Trimble's fourth-quarter 2024 results impress with strong organic ARR growth and solid 2025 guidance, boosting confidence in profitability and...

CW's total sales in the fourth quarter of 2024 surpass the Zacks Consensus Estimate by 4.9%. The top line also increases 4.9% from the year-ago level.

LKQ reports mixed fourth-quarter results and expects 2025 parts and services organic revenue growth in the range of 0-2% year over year.

Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.

Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the announcement.

ATUS reported a top-line contraction year over year in the fourth quarter of 2024, owing to declining net sales in multiple segments.

NWL reports a sales decline in fourth-quarter 2024, owing to a core sales drop of 3% year over year.

HAS' fourth-quarter top line reflects dismal contributions from The Wizards of the Coast, and Digital Gaming and Consumer Products segments.

Amicus' fourth-quarter 2024 earnings miss estimates while revenues beat the same.